LPL Financial’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.26M	Sell	411,385 -21,747	-5%	-$84K	﹤0.01%	3960
2025 Q4	$1.77M	Buy	433,132 +34,084	+9%	+$169K	﹤0.01%	3521
2025 Q3	$1.95M	Buy	399,048 +40,904	+11%	+$215K	﹤0.01%	3341
2025 Q2	$1.81M	Sell	358,144 -66,946	-16%	-$329K	﹤0.01%	3215
2025 Q1	$2.25M	Buy	425,090 +57,305	+16%	+$418K	﹤0.01%	2844
2024 Q4	$2.49M	Buy	367,785 +7,347	+2%	+$49.4K	﹤0.01%	2670
2024 Q3	$2.38M	Buy	360,438 +40,969	+13%	+$294K	﹤0.01%	2563
2024 Q2	$2.4M	Buy	319,469 +111,647	+54%	+$974K	﹤0.01%	2445
2024 Q1	$2.07M	Buy	207,822 +68,320	+49%	+$761K	﹤0.01%	2510
2023 Q4	$1.38M	Buy	139,502 +71,092	+104%	+$507K	﹤0.01%	2760
2023 Q3	$523K	Buy	68,410 +17,205	+34%	+$172K	﹤0.01%	3455
2023 Q2	$383K	Buy	51,205 +15,145	+42%	+$106K	﹤0.01%	3667
2023 Q1	$241K	Sell	36,060 -9,800	-21%	-$77.7K	﹤0.01%	3909
2022 Q4	$354K	Buy	45,860 +4,097	+10%	+$40.2K	﹤0.01%	3536
2022 Q3	$444K	Sell	41,763 -474	-1%	-$4.8K	﹤0.01%	3262
2022 Q2	$344K	Buy	+42,237	New	+$283K	﹤0.01%	3521